RECENT NEWS

A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists, and the International AIDS Vaccine Initiative, has the potential to protect humans from developing HIV infection and AIDS.

Laboratory consumables firm Eppendorf, through its European outreach activities, is supporting various initiatives dedicated to addressing persistent challenges in STEM education.

Beckman Coulter Diagnostics has received the CE mark under IVDR for its Access p-Tau217 assay, a blood test designed to support clinical evaluation of amyloid pathology in patients with signs and symptoms of cognitive decline.

NHS England is aiming to improve vaccine coverage with a new campaign drive targeting children aged from 12 months to 11 years old who have missed one or both doses of the measles vaccine.

HORIBA has announced the launch of Yumivet, its new veterinary diagnostics brand, alongside the introduction of the Yumivet VH2500 haematology analyser, offering fast, reliable diagnostics across many animal species.

A new AI model called COMPASS uses tumour gene expression data to predict which patients will respond to the cancer immunotherapy agents called immune checkpoint inhibitors (ICIs).

The UK has joined the world’s largest rare-diseases research partnership, the European Rare Diseases Research Alliance (ERDERA).

Countable Labs and Promega have announced a co-marketing agreement which brings together the capabilities of the Promega Maxwell System for nucleic acid extraction and the Countable PCR instruments for complete, bias-free DNA and RNA extraction and quantification.

The Institute of Biomedical Science (IBMS) has welcomed the publication of Pathology Transformation Review 2026 and its recognition that pathology is central to the future of the NHS. This evidence-based report, authored by Lord Carter, highlights the need to recognise pathology as a core clinical service requiring sustained investment, proactive workforce planning and better use of its professional expertise.

UK NEQAS for Microbiology and Parasitology will be hosting its annual Scientific Meeting on 27 November 2026 in Central London.

Epredia has expanded its portfolio of slide printers with the new SlideMate Thermal Slide Printer (TSP), which delivers on-demand slide printing and enhanced traceability for pathology laboratories.

A new research project based in Germany is investigating how gut microbiome data can in future be used for diagnostics, disease monitoring and personalised therapies to tackle inflammatory bowel disease.

A new study from Ben-Gurion University of the Negev (BGU) has revealed that damage to blood stem cells caused by long-term Salmonella infections is completely reversible with a course of antibiotics.

Genomics England’s 2026 Research Summit brought together researchers, clinicians, industry partners, and technologists in a showcase of the science driving genomic medicine forward.

The UK Health Security Agency (UKHSA) has partnered with The Pirbright Institute and the University of Glasgow to create the Viral Research Institutes (VRI); a strategic partnership which will ensure a collaborative approach to UK epidemic preparedness, advanced virology research and the training of future scientists.

Roche has announced the launch of AXELIOS 1 next-generation sequencing platform based on its SBX technology, offering accuracy, speed, flexibility, scalability and cost efficiency that the company says addresses critical bottlenecks in genomics and potentially in clinical research.

Scientists have discovered that two common human pathogens can work together by managing copper in their shared environment - a finding that could open new ways to break down stubborn mixed biofilms.

Nearly 2,000 people unknowingly living with HIV have been diagnosed by a pioneering NHS programme, which tests anyone needing a blood test in A&E, saving lives and preventing new infections, new figures show.

Menarini Diagnostics UK has announced it has received Coronavirus Test Device Approval (CTDA) for the Coyote FlashDetect SARS-CoV-2, Influenza A, Influenza B, Respiratory Syncytial Virus assay.

Merck has announced it has entered into a definitive agreement to acquire US-based life sciences firm Bio-Techne Corporation for a total enterprise value of approximately US$11.3 billion.